Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Pabinger

Showing results (161-170 of 211) with videos related to

Pageof 22
Sort By:
British Journal of Haematology|March 1, 1995
Antithrombins Southport (Leu 99 to Val) and Vienna (Gln 118 to Pro): two novel antithrombin variants with abnormal heparin bindingV Chowdhury, B Mille, R J Olds, et al.
Journal of Thrombosis and Haemostasis : JTH|February 7, 2017
Safety, efficacy and pharmacokinetics of rVIII-SingleChain in children with severe hemophilia A: results of a multicenter clinical trialO Stasyshyn, C Djambas Khayat, G Iosava, et al.
British Journal of Haematology|August 1, 1993
Identification of nine novel mutations in type I antithrombin deficiency by heteroduplex screeningV Chowdhury, R J Olds, D A Lane, et al.
Journal of Thrombosis and Haemostasis : JTH|December 2, 2011
Mortality and inherited thrombophilia: results from the European Prospective Cohort on ThrombophiliaI Pabinger, C Y Vossen, J Lang, et al.
British Journal of Haematology|January 1, 1994
Randomized double-blind, placebo-controlled trial of twice-daily zidovudine in asymptomatic haemophiliacs infected with the human immunodeficiency virus type 1. European-Australian Haemophilia Collaborative Study GroupP M Mannucci, A Gringeri, G Savidge, et al.
British Journal of Haematology|May 8, 1999
Homocysteine levels in polycythaemia vera and essential thrombocythaemiaH Gisslinger, F Rodeghiero, M Ruggeri, et al.
Vox Sanguinis|November 5, 2011
Treatment of primary autoimmune thrombocytopenia (AITP) [1]M R Schipperus, R Fijnheer, I Pabinger, et al.
Hamostaseologie|May 1, 2009
[Relevance of a single dose of 270 microg/kg recombinant factor VIIa for the treatment of patients with haemophilia and inhibitors - Recommendations from the GTH experts]Günter Auerswald, W Muntean, B Kemkes-Matthes, et al.
Journal of Thrombosis and Haemostasis : JTH|April 21, 2018
Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolismP Mir Seyed Nazari, J Riedl, M Preusser, et al.
Leukemia|February 24, 2001
Prognosis of patients with a second relapse of acute myeloid leukemiaB Stoiser, P Knöbl, C Fonatsch, et al.
Pageof 22

Showing results (161-170 of 211) with videos related to

Sort By:
Pageof 22
British Journal of Haematology|March 1, 1995
Antithrombins Southport (Leu 99 to Val) and Vienna (Gln 118 to Pro): two novel antithrombin variants with abnormal heparin bindingV Chowdhury, B Mille, R J Olds, et al.
Journal of Thrombosis and Haemostasis : JTH|February 7, 2017
Safety, efficacy and pharmacokinetics of rVIII-SingleChain in children with severe hemophilia A: results of a multicenter clinical trialO Stasyshyn, C Djambas Khayat, G Iosava, et al.
British Journal of Haematology|August 1, 1993
Identification of nine novel mutations in type I antithrombin deficiency by heteroduplex screeningV Chowdhury, R J Olds, D A Lane, et al.
Journal of Thrombosis and Haemostasis : JTH|December 2, 2011
Mortality and inherited thrombophilia: results from the European Prospective Cohort on ThrombophiliaI Pabinger, C Y Vossen, J Lang, et al.
British Journal of Haematology|January 1, 1994
Randomized double-blind, placebo-controlled trial of twice-daily zidovudine in asymptomatic haemophiliacs infected with the human immunodeficiency virus type 1. European-Australian Haemophilia Collaborative Study GroupP M Mannucci, A Gringeri, G Savidge, et al.
British Journal of Haematology|May 8, 1999
Homocysteine levels in polycythaemia vera and essential thrombocythaemiaH Gisslinger, F Rodeghiero, M Ruggeri, et al.
Vox Sanguinis|November 5, 2011
Treatment of primary autoimmune thrombocytopenia (AITP) [1]M R Schipperus, R Fijnheer, I Pabinger, et al.
Hamostaseologie|May 1, 2009
[Relevance of a single dose of 270 microg/kg recombinant factor VIIa for the treatment of patients with haemophilia and inhibitors - Recommendations from the GTH experts]Günter Auerswald, W Muntean, B Kemkes-Matthes, et al.
Journal of Thrombosis and Haemostasis : JTH|April 21, 2018
Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolismP Mir Seyed Nazari, J Riedl, M Preusser, et al.
Leukemia|February 24, 2001
Prognosis of patients with a second relapse of acute myeloid leukemiaB Stoiser, P Knöbl, C Fonatsch, et al.
Pageof 22